A randomized phase 3 open label study of nivolumab vs. temozolomide each in combination with radiation therapy in newly diagnosed adult subjects with unmethylated MGMT (tumor o-6-methylguanine DNA methyltransferase) glioblastoma. The gene discussed is MGMT; the disease is glioblastoma.